Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic Acid
2. Ono 5046
3. Ono-5046
4. Ono-ei-600
5. Sivelestat
1. Sivelestat Sodium Tetrahydrate
2. 201677-61-4
3. Sivelestat Sodium Hydrate
4. Elaspol
5. Ono-5046.na
6. Ly544349 Sodium Hydrate
7. Sivelestat (sodium Tetrahydrate)
8. Sivelestat Sodium [usan]
9. Ei-546
10. Ono 5046
11. Sivelestat Sodium (usan)
12. Ono-5046 Sodium Hydrate
13. Sivelestat Sodium Salt Tetrahydrate
14. Ly-544349 Sodium Hydrate
15. 737rr8y409
16. Sodium;2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetate;tetrahydrate
17. Dsstox_cid_26727
18. Dsstox_rid_81857
19. Dsstox_gsid_46727
20. Glycine, N-(2-(((4-(2,2-dimethyl-1-oxopropoxy)phenyl)sulfonyl)amino)benzoyl)-, Monosodium Salt, Tetrahydrate
21. Sodium ((2-(((4-((2,2-dimethylpropanoyl)oxy)phenyl)sulfonyl)amino)benzoyl)amino)acetate Tetrahydrate
22. Ono5046-na;sodium Sivelestat;ei546 Sodium;ly544349 Sodium
23. Sodium Sivelestat
24. Sodium 2-(2-(4-(pivaloyloxy)phenylsulfonamido)benzamido)acetate Tetrahydrate
25. Ei546 Sodium Tetrahydrate;ly544349 Sodium Tetrahydrate;ono5046 Sodium Tetrahydrate
26. Sodium,2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetate,tetrahydrate
27. Elaspol (tn)
28. Ei546 Sodium
29. Cas-201677-61-4
30. Ly544349 Sodium
31. Ncgc00167577-01
32. Ono5046-na
33. Unii-737rr8y409
34. Sivelestatsodiumhydrate
35. Elaspol Sodium Salt Tetrahydrate
36. Chembl3182314
37. Dtxsid0046727
38. Chebi:32133
39. Sivelestat (sodium Salt Hydrate)
40. Sivelestat Sodium [mart.]
41. Sivelestat Sodium Hydrate (jp17)
42. Sivelestat Sodium [who-dd]
43. Act02667
44. Bcp09535
45. Tox21_112570
46. Hy-17443b
47. S4666
48. Akos015901086
49. Akos015963357
50. Tox21_112570_1
51. Ac-1291
52. Ccg-269903
53. Cs-3380
54. Sivelestat Sodium Hydrate [jan]
55. Sivelestat Sodium For Injection (jp17)
56. Ncgc00263570-01
57. Ft-0748809
58. D01918
59. Sivelestat Sodium Salt Tetrahydrate [mi]
60. A909240
61. J-013081
62. Q27266149
63. Sodium ((2-(((4-((2,2-dimethylpropanoyl)oxy)phenyl)sulfonyl)amino)benzoyl)amino)acetate Tetrahydrate
Molecular Weight | 528.5 g/mol |
---|---|
Molecular Formula | C20H29N2NaO11S |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 9 |
Exact Mass | 528.13897520 g/mol |
Monoisotopic Mass | 528.13897520 g/mol |
Topological Polar Surface Area | 154 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 738 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 6 |
Serine Proteinase Inhibitors
Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
59
PharmaCompass offers a list of Sivelestat Sodium Hydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sivelestat Sodium Hydrate manufacturer or Sivelestat Sodium Hydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sivelestat Sodium Hydrate manufacturer or Sivelestat Sodium Hydrate supplier.
PharmaCompass also assists you with knowing the Sivelestat Sodium Hydrate API Price utilized in the formulation of products. Sivelestat Sodium Hydrate API Price is not always fixed or binding as the Sivelestat Sodium Hydrate Price is obtained through a variety of data sources. The Sivelestat Sodium Hydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AKOS015963357 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AKOS015963357, including repackagers and relabelers. The FDA regulates AKOS015963357 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AKOS015963357 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AKOS015963357 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A AKOS015963357 supplier is an individual or a company that provides AKOS015963357 active pharmaceutical ingredient (API) or AKOS015963357 finished formulations upon request. The AKOS015963357 suppliers may include AKOS015963357 API manufacturers, exporters, distributors and traders.
click here to find a list of AKOS015963357 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A AKOS015963357 DMF (Drug Master File) is a document detailing the whole manufacturing process of AKOS015963357 active pharmaceutical ingredient (API) in detail. Different forms of AKOS015963357 DMFs exist exist since differing nations have different regulations, such as AKOS015963357 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A AKOS015963357 DMF submitted to regulatory agencies in the US is known as a USDMF. AKOS015963357 USDMF includes data on AKOS015963357's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The AKOS015963357 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of AKOS015963357 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The AKOS015963357 Drug Master File in Japan (AKOS015963357 JDMF) empowers AKOS015963357 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the AKOS015963357 JDMF during the approval evaluation for pharmaceutical products. At the time of AKOS015963357 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of AKOS015963357 suppliers with JDMF on PharmaCompass.
AKOS015963357 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AKOS015963357 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AKOS015963357 GMP manufacturer or AKOS015963357 GMP API supplier for your needs.
A AKOS015963357 CoA (Certificate of Analysis) is a formal document that attests to AKOS015963357's compliance with AKOS015963357 specifications and serves as a tool for batch-level quality control.
AKOS015963357 CoA mostly includes findings from lab analyses of a specific batch. For each AKOS015963357 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AKOS015963357 may be tested according to a variety of international standards, such as European Pharmacopoeia (AKOS015963357 EP), AKOS015963357 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AKOS015963357 USP).